MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0001128
Prosperity Drugs Private Limited
Prosperity Drugs Private Limited - pharma in Solan, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹131.43 Cr
▼ 1% YoY
Net profit · FY 2025
₹66.85 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹8.39 Cr
EBITDA margin 6.4%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹7 Cr
Issued & subscribed
Open charges
₹49.76 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
139
Provident fund records
About Prosperity Drugs Private Limited
Data last updated:
Prosperity Drugs Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24290HP2019PTC007481. Its GSTIN is 02AAKCP5894L1ZU (Himachal Pradesh).
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹7 Cr. It is led by directors including Banshidhar Kanhaiyalal and Bharat Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hb – 162 Village – Belikhol Near Kharuni Belikhol, Solan, Himachal Pradesh, India – 174101.
As per the financials filed for FY 2025, the company reported a revenue of ₹131.43 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹66.85 Lakh (net margin 0.5%) and EBITDA of ₹8.39 Cr (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
The company has about 139 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹49.76 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹5 Cr; the latest was in October 2020. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Makers Laboratories Ltd with revenue of ₹132.64 Cr.
Prosperity Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0001128).
Company details
CIN U24290HP2019PTC007481
Registration Number 007481
Incorporation Date 04 June 2019
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0001128
Recognitions & Rankings of Prosperity Drugs
Contact details
Prosperity Drugs Private Limited's registered office is in Solan, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHb – 162 Village – Belikhol Near Kharuni Belikhol, Solan, Himachal Pradesh, India – 174101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Prosperity Drugs Private Limited, buy the company report.
Comprehensive company report
Prosperity Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prosperity Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Prosperity Drugs Private Limited, buy the company report.
Financials of Prosperity Drugs Private Limited
FY 2024 filings availableProsperity Drugs Private Limited reported revenue of ₹131.43 Cr (down 1% YoY) for FY 2025.
Revenue · FY 2025
₹131.43 Cr ▼ 1%
Net profit · FY 2025
₹66.85 Lakh margin 0.5%
EBITDA · FY 2025
₹8.39 Cr margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 26%
Revenue fell 1% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prosperity Drugs Private Limited, buy the company report.
Board of directors of Prosperity Drugs Private Limited
Prosperity Drugs has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Banshidhar Kanhaiyalal Also directs: Evets Drugs Private Limited, Sriram Healthcare Private Limited, Acme Therapeutics (I) Private Limited and 2 more | Director | 04 Jun 2019 | 7 Years 5 Months | Current |
| Bharat Bansal | Director | 04 Jun 2019 | 7 Years 5 Months | Current |
| Parminder Bansal | Director | 04 Jun 2019 | 7 Years 5 Months | Current |
| Murlidhar Kanhaiyalal Also directs: Evets Drugs Private Limited, Sriram Healthcare Private Limited, Evets Packaging Private Limited and 1 more | Director | 04 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Prosperity Drugs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Makers Laboratories Ltd | ₹132.64 Cr (FY 2025) | 25.0% | Mumbai, Maharashtra, India | |||
| Saimirra Innopharm Private Limited | ₹132.6 Cr (FY 2025) | 65.0% | Chennai, Tamil Nadu, India | |||
| Bengal Chemicals and Pharmaceuticals Ltd | ₹132.57 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India | |||
| Prosperity Drugs Private Limitedthis company | ₹131.43 Cr (FY 2025) | ₹66.85 Lakh | 0.5% | -1.0% | 139 | Solan, Himachal Pradesh, India |
| Dey's Medical Stores (Manufacturing) Ltd | ₹130.35 Cr (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Elder Prroject Limited | ₹129.37 Cr (FY 2022) | 18.0% | Mumbai, Maharashtra, India | |||
| Maxim Pharmaceuticals Private Limited | ₹129.31 Cr (FY 2025) | -6.0% | Pune, Maharashtra, India | |||
| Koye Pharmaceuticals Private Limited | ₹129.09 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Centurion Remedies Private Limited | ₹128.35 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Prosperity Drugs Private Limited, buy the company report.
Auditor
Prosperity Drugs Private Limited is audited by M/s Dhillon & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s Dhillon & Associates | FY 2024 | 002783N |
Shareholding
The shareholding of Prosperity Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prosperity Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹49.76 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 2020 | 100395897 | Hdfc Bank Limited | ₹49.76 Cr | Open |
To see the full charge records of Prosperity Drugs Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Prosperity Drugs Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹5 Cr; the latest was in October 2020.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹5 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2020 | Funding round | ₹5 Cr | Investors: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Prosperity Drugs Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Court case (Motor Vehc Act) | Filed against the company by State of HP | Disposed |
To see the full case history of Prosperity Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prosperity Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Prosperity Drugs Private Limited has a workforce of 139 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
Employee count
139
Active EPFO establishments
1
Employee growth
-5.44%
GST
Prosperity Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAKCP5894L1ZU | Himachal Pradesh | Active | 27 Aug 2020 |
To see the full GST registrations and return filing status of Prosperity Drugs Private Limited, buy the company report.
Recent activity
Prosperity Drugs Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Banshidhar Kanhaiyalal was appointed as Director on 04 Jun 2019.
Charges
A charge with Hdfc Bank Limited of Rs. 49.76 Cr registered on 29 Oct 2020 with Charge ID 100395897 was modified on 05 Feb 2025.
AGM
Prosperity Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Prosperity Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 49.76 Cr with Charge ID 100395897 was registered on 29 Oct 2020.
Appointed
Banshidhar Kanhaiyalal was appointed as Director.
Appointed
Bharat Bansal was appointed as Director.
Appointed
Murlidhar Kanhaiyalal was appointed as Director.
Appointed
Parminder Bansal was appointed as Director.
Incorporation
04 Jun 2019
Prosperity Drugs Private Limited was registered on 04 Jun 2019 with Roc Himachal Pradesh & aged 7 years 5 months as per MCA records.
Frequently asked questions
Prosperity Drugs is an active private limited company based in Solan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 June 2019 (7+ years old) and is registered under CIN U24290HP2019PTC007481.
Prosperity Drugs has 4 current directors:
- Banshidhar Kanhaiyalal - Director
- Bharat Bansal - Director
- Parminder Bansal - Director
- Murlidhar Kanhaiyalal - Director
The latest financial statements of Prosperity Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Prosperity Drugs is 02AAKCP5894L1ZU, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Prosperity Drugs is U24290HP2019PTC007481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prosperity Drugs has 1 court case on record: 1 filed against it.
Prosperity Drugs was incorporated on 04 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Prosperity Drugs has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹5 Cr; the latest was in October 2020.
The peers of Prosperity Drugs by revenue are Makers Laboratories Ltd, Saimirra Innopharm Private Limited, Bengal Chemicals and Pharmaceuticals Ltd, Dey's Medical Stores (Manufacturing) Ltd, Elder Prroject Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Banshidhar Kanhaiyalal was appointed as Director on 04 Jun 2019. Bharat Bansal was appointed as Director on 04 Jun 2019. Murlidhar Kanhaiyalal was appointed as Director on 04 Jun 2019. Prosperity Drugs has 4 board changes on record in total.
Yes, Prosperity Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0001128).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages